Mitotech SA
🇱🇺Luxembourg
- Country
- 🇱🇺Luxembourg
- Ownership
- Subsidiary
- Established
- 2009-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 2
1 (33.3%)Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome
Phase 3
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Drug: SkQ1 Vehicle SolutionDrug: SkQ1 Ophthalmic Solution
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Mitotech, SA
- Target Recruit Count
- 610
- Registration Number
- NCT04206020
- Locations
- 🇺🇸
Arizona Eye Institute and Cosmetic Laser, Sun City West, Arizona, United States
🇺🇸Andover Eye Associates, Andover, Massachusetts, United States
🇺🇸Eye Clinics of South Texas, San Antonio, Texas, United States
Study of SkQ1 as Treatment for Dry-eye Syndrome
Phase 3
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Drug: SkQ1 (Vehicle)Drug: Low Dose - SkQ1Drug: High dose - SkQ1
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Mitotech, SA
- Target Recruit Count
- 452
- Registration Number
- NCT03764735
- Locations
- 🇺🇸
Cornea & Cataract Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Eye Care Insititute, Louisville, Kentucky, United States
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
Phase 2
Completed
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- Drug: Placebo (Vehicle) opthalmic solutionDrug: Low Dose 0.155µg/mL SkQ1 ophthalmic solutionDrug: High Dose 1.55µg/mL SkQ1 ophthalmic solution
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Mitotech, SA
- Target Recruit Count
- 91
- Registration Number
- NCT02121301
- Locations
- 🇺🇸
Lawrence General Hospital, Andover, Massachusetts, United States
News
No news found